# EDGAR Filing Document

**Accession Number:** 0001567264
**File Stem:** 0001213900-23-011620
**Filing Date:** 2023-2
**Character Count:** 2051
**Document Hash:** acabc0c69961df475f7ac0aae4e5be26
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-011620.hdr.sgml**: 20230728

**ACCESSION NUMBER**: 0001213900-23-011620

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230214

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INTENSITY THERAPEUTICS, INC.
- **CENTRAL INDEX KEY:** 0001567264
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 461488089
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 61 WILTON ROAD, 3RD FLOOR
- **CITY:** WESTPORT
- **STATE:** CT
- **ZIP:** 06880
- **BUSINESS PHONE:** 203-221-7381

**MAIL ADDRESS:**
- **STREET 1:** 61 WILTON ROAD, 3RD FLOOR
- **CITY:** WESTPORT
- **STATE:** CT
- **ZIP:** 06880

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Intensity Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20130117

February 14, 2023

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission<br> Division of Corporation Finance<br> 100 F Street, N.E.<br> Washington, D.C. 20549

Re: Intensity Therapeutics, Inc.<br> Registration Statement on Form S-1<br> File No. 333-260565

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on February 9, 2023, in which we, as representative of the several underwriters of Intensity Therapeutics, Inc.'s proposed public offering, joined Intensity Therapeutics, Inc.'s request for acceleration of the effective date of the above-referenced Registration Statement for February 13, 2023, at 4:30 p.m. Eastern Time. Intensity Therapeutics, Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

Very truly yours,

THE BENCHMARK COMPANY, LLC

As representative of the

several Underwriters

---

| | |
|:---|:---|
| By: | /s/ Michael Jacobs |
| Name: | Michael Jacobs |
| Title: | MD/Head of ECM |

---